Wikipedia
Enumeral
Enumeral is a US biotechnology company which develops monoclonal antibody immunotherapies through an 'immunoprofiling' platform that allows it to scan the human immune microenvironment and identify and validate potential drug candidates. The company’s initial focus is on immunomodulators that target immune checkpoint proteins. The initial checkpoints targeted are PD-1, TIM3, LAG3, TIGIT, VISTA and OX40.